📢 GI REACH Update We’re getting ready for our official launch in November 2025! 🚀 ✅ Website under construction gi-reach.com ✅ Building systems for mentees, consultants & team to work together ✅ Preparing our first waiting list for early members #MedicalResearch

📊 New study: Eosinophilic Esophagitis (EoE) inflammation is patchy — and 10% of cases are missed if you biopsy only the distal esophagus. 💡 Key takeaway: Always biopsy distal + middle esophagus. 🔍 No cases with isolated proximal eosinophilia. giejournal.org/article/S0016-…

📊 Nationwide Study (2016–2020) In malignant gastric outlet obstruction, endoscopic gastrojejunostomy (EGJ) vs surgical (SGJ): ✅ ↓ Respiratory failure, Blood transfusion, Peritonitis, Shorter stay & lower cost ➡️ EGJ use ↑ from 17% → 24% in 5 yrs giejournal.org/article/S0016-…

📢 Tired of unethical shortcuts? At GI REACH, we don’t “do papers for people.” We build ethical research teams, mentor with purpose, and credit those who actually work. Launching November. 📱 WhatsApp: +44 7377 924476 #GIREACH #MetaAnalysis #MedTwitter #EthicalPublishing

🚨 New study alert! GLP-1 receptor agonists (GLP-1RAs) 📈 increase the risk of retained gastric contents during upper endoscopy. 🔹 Odds of solid RGC: OR 3.8 🔹 Higher aborted procedures 🔹 No ↑ in anesthesia complications giejournal.org/article/S0016-…

🚀 Medical research shouldn’t take years without mentorship. At GI REACH, we connect ideas with trained teams, ensuring ethical, timely, and publishable research. 🌐 Website launching Nov → gi-reach.com 📲 Join the waiting list via WhatsApp: +44 7377 924476 #GIREACH

Grateful for the growing attention from residency programs Thank you Cooper IM Residency for the follow! Our mission is to empower residents & fellows with task-based research training and publication pathways while building toward future collaborations with institutions. #MedTwitter

A proud milestone 6 abstracts accepted at #ACG2025, all now submitted as full manuscripts to top GI & obesity journals. GI REACH is on a mission to expand global collaborations, empower residents & fellows, and launch officially this November. ACG

🧬 NGS in Pancreatic Cysts = Game Changer In a study of 441 patients, next-gen sequencing changed management in 26.1% of cases—guiding surgery, clarifying cyst type, and improving precision. #Pancreas #GI #NGS #MedTwitter GIE giejournal.org/article/S0016-…

At GI REACH, we believe transparency builds trust. We are fully open to independent credibility & ethics checks by academic bodies, research organizations, or compliance authorities. Our mission is clear: ethical, impactful, and collaborative research #GIREACH #researchethics

“You need to be stubborn on your vision, but very flexible on the details.” — Jeff Bezos

🔬 ME-OE (Magnification Endoscopy + Optical Enhancement) outperforms white-light endoscopy for detecting GIM, GIN, & early gastric cancer. 📈 Higher yield (36.6% vs 23.8%) ✅ Better sensitivity, accuracy & consistency 🧪 NCT04411589 giejournal.org/article/S0016-…

link.springer.com/article/10.100…

🚀 At GI REACH, we’re more than a platform — we’re a team. 🔹 A growing, credible, global community. Stay tuned. 🌍✨ #GIREACH #MedTwitter #GIResearch

My friends discussing the role of AI during colonoscopy - check out the podcast! 🎙️🎧

Honored to serve as Guest Editor for the Cureus Collection: ‘Therapeutic Endoscopy in Metabolic and Chronic Disease: Innovations in Prevention and Treatment’ A step forward in advancing GI research & fostering global collaboration through GI REACH and Cureus 🌍

Next GI REACH cohort starts November! Choose a task in a real ongoing project Learn it in a live teaching session Apply it under supervision ✅ Earn a confirmed PubMed-indexed publication Join waiting list now: +44 7377 924476 Be first to choose projects when enrolment opens!

🌍 The future of research is collaboration, speed & impact. At GI REACH, we’re building a movement where young researchers don’t just learn — they publish, inspire, and lead. This November, join us to be part of something bigger. 🚀 📲 Waiting list: +44 7377 924476 #MedTwitter

📊 In 53 patients with complicated diverticulitis, EUS-guided abscess drainage with LAMS showed: ✅ 92.5% technical success ✅ 88.7% clinical success ⚠️ 3.8% adverse events 🛑 Reduced urgent surgeries A promising alternative to percutaneous drainage. giejournal.org/article/S0016-…